USA / Pharma Innovation Factsheet 2020
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US innovation today and its long term sustainability. See below for data on…
In a recent article for PharmaBoardroom, Objective Capital’s David Crean took a look at the state of US innovation today and its long term sustainability. See below for data on…
Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you the seven biggest biotech IPOs this year. Notably, six of the seven companies…
Singapore is home to a wide range of biopharmaceutical company headquarters, many of them regional bases, and clusters. Made with Visme Infographic Maker Singaporean pharma exports are projected to grow…
Singapore is far ahead of its Asia-Pacific peers in terms of GDP per person. Made with Visme Infographic Maker Singapore was ranked Asia-Pacific’s, and indeed the world’s, most competitive country/region…
In just a few years, Switzerland has fallen from first to fifth place in the Global Competitiveness Index. The country is also losing ground in various subindexes, such as that…
An overview of health and healthcare in Belgium with data on the country’s leading causes of death, healthcare expenditure and hospital infrastructure. The top 10 causes of death in…
Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics, pharmaceutical and biologics spending, production costs, and pricing changes. Canada pharma data overview. Made…
A selection of data on the Nordic pharma markets (Denmark, Finland, Iceland, Norway, and Sweden), including market value, R&D spend, production, exports and imports, employment, generics penetration, and healthcare spending…
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10 corporations account for 50 percent of total sales and…
The Top 15 pharmaceutical companies in Norway ranked by sales turnover in 2019. The market is dominated by multinationals, with Novartis, Pfizer and MSD making up the top three positions.…
In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments. However, much work remains to be done in targeting and eliminating…
Below we present a list of the top 5 public biopharma companies that focus on developing RNA-based therapies. RNA interference (RNAi) is a natural mechanism which is present in living…
See our Cookie Privacy Policy Here